Omico's Bruce Goodwin says the launch of Australia's largest cancer genomics initiative, known as PrOSPeCT, signals the next step for a project that is already benefiting patients but also has the potential to create a new accessible platform for clinical trials and a framework for policy reform. …
Omico's Bruce Goodwin on PrOSPeCT trials as a platform for change
July 28, 2023 Latest NewsBioPharmaBioPharmaDispatch Executive
Latest Video
New Stories
-
The symptoms have been identified, but the widely held belief about the cause is a miss
September 30, 2025 - - Latest News -
UK companies are granted more time to decide on pricing agreement
September 29, 2025 - - Latest News -
Anatara strengthens board with the appointment of Dirk van Dissel
September 29, 2025 - - Australian Biotech -
CLINUVEL advances next-generation peptide drug formulations
September 29, 2025 - -
Alterity Therapeutics targets major market with ATH434 in Multiple System Atrophy
September 29, 2025 - - Australian Biotech -
Lower than expected uptake of new therapies impacts PBS spend
September 29, 2025 - - Latest News -
Chimeric reports encouraging early data from CHM CDH17 trial
September 29, 2025 - - Australian Biotech